This line has been broadened and aimed at this disorder (complication) of diabetes mellitus type 2, mainly towards its repercussions on new medical treatments and new therapeutics in which drugs are used for better metabolic control and future stabilisation of diabetes mellitus. The repercussions on HbA1c control are also sought, as well as the complications, taking into account the application of new continuous insulin infusion systems.